MX2020005841A - Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6. - Google Patents

Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6.

Info

Publication number
MX2020005841A
MX2020005841A MX2020005841A MX2020005841A MX2020005841A MX 2020005841 A MX2020005841 A MX 2020005841A MX 2020005841 A MX2020005841 A MX 2020005841A MX 2020005841 A MX2020005841 A MX 2020005841A MX 2020005841 A MX2020005841 A MX 2020005841A
Authority
MX
Mexico
Prior art keywords
inhibitors
histone deacetylase
oxadiazole derivatives
compounds
relates
Prior art date
Application number
MX2020005841A
Other languages
English (en)
Inventor
González Elena Carceller
Solana Jorge Salas
Muñoz Alberto Ortega
Original Assignee
Oryzon Genomics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryzon Genomics Sa filed Critical Oryzon Genomics Sa
Publication of MX2020005841A publication Critical patent/MX2020005841A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

La invención se refiere a compuestos de la Fórmula (I) como se describe en la presente, útiles como inhibidores de histona-desacetilasa 6 (HDAC6). La invención también se refiere a composiciones farmacéuticas que comprenden estos compuestos y a su uso en terapia.
MX2020005841A 2017-12-05 2018-12-05 Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6. MX2020005841A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382835 2017-12-05
EP18382562 2018-07-26
PCT/EP2018/083655 WO2019110663A1 (en) 2017-12-05 2018-12-05 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors

Publications (1)

Publication Number Publication Date
MX2020005841A true MX2020005841A (es) 2020-09-07

Family

ID=64556931

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020005841A MX2020005841A (es) 2017-12-05 2018-12-05 Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6.

Country Status (12)

Country Link
US (2) US20200339569A1 (es)
EP (1) EP3720851A1 (es)
JP (1) JP7369458B2 (es)
KR (1) KR20200097294A (es)
CN (1) CN111406054B (es)
AU (1) AU2018379321A1 (es)
BR (1) BR112020010534A2 (es)
CA (1) CA3083061A1 (es)
IL (1) IL274973B1 (es)
MX (1) MX2020005841A (es)
SG (1) SG11202005254RA (es)
WO (1) WO2019110663A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10357493B2 (en) 2017-03-10 2019-07-23 Selenity Therapeutics (Bermuda), Ltd. Metalloenzyme inhibitor compounds
WO2020245381A1 (en) * 2019-06-06 2020-12-10 Oryzon Genomics, S.A. 3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors
KR102576148B1 (ko) * 2020-04-13 2023-09-07 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
KR20220030134A (ko) * 2020-09-02 2022-03-10 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 새로운 구조의 화합물 및 이를 포함하는 약제학적 조성물
CA3215958A1 (en) 2021-04-23 2022-10-27 Tenaya Therapeutics, Inc. Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy
TW202308619A (zh) 2021-05-04 2023-03-01 美商特納亞治療股份有限公司 用於治療代謝疾病和hfpef的hdac6抑制劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1870401A4 (en) * 2005-04-06 2011-06-15 Msd Kk SUBSTITUTE DERIVATIVE PIPERAZINE IN 1,4
WO2013066839A2 (en) 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
BR112014012815A8 (pt) * 2011-11-28 2017-06-20 Novartis Ag derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
JPWO2017033946A1 (ja) 2015-08-25 2018-06-07 武田薬品工業株式会社 複素環化合物
EP3436445B1 (en) 2016-03-15 2023-09-06 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
WO2017222952A1 (en) 2016-06-23 2017-12-28 Merck Sharp & Dohme Corp. 3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
PL3558984T3 (pl) 2016-12-20 2024-01-15 Fmc Corporation Oksadiazole grzybobójcze

Also Published As

Publication number Publication date
US20200339569A1 (en) 2020-10-29
JP2021505684A (ja) 2021-02-18
BR112020010534A2 (pt) 2020-10-20
RU2020121391A3 (es) 2022-01-20
KR20200097294A (ko) 2020-08-18
AU2018379321A1 (en) 2020-06-11
WO2019110663A1 (en) 2019-06-13
JP7369458B2 (ja) 2023-10-26
EP3720851A1 (en) 2020-10-14
RU2020121391A (ru) 2022-01-10
US20230026909A1 (en) 2023-01-26
IL274973B1 (en) 2024-03-01
CN111406054A (zh) 2020-07-10
CN111406054B (zh) 2024-01-02
CA3083061A1 (en) 2019-06-13
IL274973A (en) 2020-07-30
SG11202005254RA (en) 2020-07-29

Similar Documents

Publication Publication Date Title
MX2020005841A (es) Derivados de 1,2,4-oxadiazol como inhibidores de histona-desacetilasa 6.
PH12020550857A1 (en) Polycyclic compounds as allosteric shp2 inhibitors
WO2018136264A9 (en) Pyridine compounds as allosteric shp2 inhibitors
PH12020550216A1 (en) Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
MD4800C1 (ro) Compuşi de aminopirimidinil ca inhibitori de JAK
EA201891229A1 (ru) Eif4a-ингибирующие соединения и связанные с ними способы
PH12017501669A1 (en) Alpha-cinnamide compounds and compositions as hdac8 inhibitors
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
AU2017269673A1 (en) Pyridine dicarboxamide derivatives as bromodomain inhibitors
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
PH12015502365B1 (en) Bace1 inhibitors
MX2016014911A (es) Acidos hidroxamicos heterociclicos como inhibidores de proteina desacetilasa e inhibidores dobles de proteina desacetilasa-proteina cinasa, y metodos de uso de los mismos.
MX2018000419A (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor.
MX2019008302A (es) Inhibidores biciclicos de histona desacetilasa.
MX2016004934A (es) Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
MX2018004304A (es) DERIVADOS DE QUINOXALINA Y PIRIDOPRAZINA COMO INHIBIDORES DE PI3Kß.
MX2020004981A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3.
MX2020001484A (es) Inhibidores bicíclicos de la histona desacetilasa.
MX2021003643A (es) Derivados de terpenoides y usos de los mismos.
PH12019501642A1 (en) Novel compounds and their use in the treatment of schistosomiasis
EA201892539A1 (ru) Пиридинильные производные, фармацевтические композиции и их применение в качестве ингибиторов аос3
PH12019501999A1 (en) Pyrazole derivatives as bromodomain inhibitors
PH12017501668A1 (en) Bace1 inhibitors